, Volume 70, Issue 2, pp 625–639 | Cite as

Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women’s breast cancer tumors

  • Nassim Faridi
  • S. Zahra Bathaie
  • Saeid Abroun
  • Parvaneh Farzaneh
  • Hamid Karbasian
  • Fuyuhiko Tamanoi
  • Mohammad-Ali Mohagheghi
Original Article


As an experimental model, most studies rely on established human cancer cell lines; however, some genetical or phenotypical differences exist between these cells and their original tumor. Therefore, primary cells isolated directly from tissue are believed to be more biologically relevant tools for studying human and animal biology. Here, we aimed to isolate primary epithelial cancer and normal cells from breast tumors of Iranian women, for the first time. Thus, we isolated the epithelial and fibroblast cells from biopsy samples of patients with breast cancer based on differential centrifugation followed by culture in selective media. Normal epithelial cells obtained from the tissue biopsy away from the core of the tumor, based on the pathological diagnosis. Flow cytometry analysis indicated the positive immunoreactivity of the isolated epithelial cells against CD24 and Epithelial Specific Antigen (ESA/EpCAM), while they displayed a concomitant low expression of CD44 and CD49f. In contrat to fibroblasts, the qPCR data indicated the expression of luminal intracellular cytokeratin (Ck18) in both normal and cancer epithelial cells, but there was no expression of myoepithelial/basal markers, CK5 and vimentin. The epithelial cancer cells were reactive to cytokeratin 19 (CK19) antibody, whereas the normal epithelial cells were not. The expression of calmodulin-like protein (CLP) was also lower in the cancer epithelial cells than in the normal ones. In conclusion, primary epithelial normal and cancer cells, in addition to the fibroblasts were isolated and characterized from breast tumor of Iranian patients; and CLP expression is suggested as a susceptibility marker for breast cancer screening.


Primary breast cell CD24 CD44 EpCAM Cytokeratin CLP 



This project was supported and funded by Iranian national Science Foundation (INSF) project No. 93036700. The authors are also thank full of the Research Console of Tarbiat Modares University for their support of this project. The authors are very thankful of Dr. Laleh Nikfarjam for her intellectual help during separation of the mentioned cells.


  1. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P (1997) CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89:3385–3395Google Scholar
  2. Alberg AJ, Singh S (2001) Epidemiology of breast cancer in older women: implications for future healthcare. Drugs Aging 18:761–772CrossRefGoogle Scholar
  3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988CrossRefGoogle Scholar
  4. Band V, Sager R (1989) Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA 86:1249–1253CrossRefGoogle Scholar
  5. Bartlett J, Going JJ, Mallon EA, Watters AD, Reeves JR, Stanton P, Richmond J, Donald B, Ferrier R, Cooke TG (2001) Evaluating HER2 amplification and overexpression in breast cancer. J Pathol 195:422–428CrossRefGoogle Scholar
  6. Berchtold MW, Koller M, Egli R, Rhyner JA, Hameister H, Strehler EE (1993) Localization of the intronless gene coding for calmodulin-like protein CLP to human chromosome 10p13-ter. Hum Genet 90:496–500CrossRefGoogle Scholar
  7. Berwald Y, Sachs L (1963) In vitro cell transformation with chemical carcinogens. Nature 200:1182–1184CrossRefGoogle Scholar
  8. Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O (2006) CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol Res Pract 202:569–576CrossRefGoogle Scholar
  9. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou J-P, Laville M, Le Marchand-Brustel Y, Tanti J-F, Vidal H (2003) Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52:1319–1325CrossRefGoogle Scholar
  10. Brooks MD, Bennett RD, Strehler EE, Sebo TJ, Eckert SE, Carr AB (2009) Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. J Prosthodont 18:11–16CrossRefGoogle Scholar
  11. Brooks MD, Bennett RD, Weaver AL, Sebo TJ, Eckert SE, Strehler EE and Carr AB (2013) Human calmodulin-like protein CALML3: a novel marker for normal oral squamous mucosa that is downregulated in malignant transformation. Int J Dent 2013:592843. CrossRefGoogle Scholar
  12. Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, Purushotham AD (2008) Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 122:298–304CrossRefGoogle Scholar
  13. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33:315–318CrossRefGoogle Scholar
  14. Durussel I, Rhyner JA, Strehler EE, Cox JA (1993) Cation binding and conformation of human calmodulin-like protein. Biochemistry 32:6089–6094CrossRefGoogle Scholar
  15. Edman CF, George SE, Means AR, Schulman H, Yaswen P (1994) Selective activation and inhibition of calmodulin-dependent enzymes by a calmodulin-like protein found in human epithelial cells. Eur J Biochem 226:725–730CrossRefGoogle Scholar
  16. Ethier SP, Ammerman CA, Dziubinski ML (2000) Isolation and culture of human breast cancer cells from primary tumors and metastases. In: Ip MM, Asch BB (eds) Methods in mammary gland biology and breast cancer research. Springer, Boston, MAGoogle Scholar
  17. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefGoogle Scholar
  18. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefGoogle Scholar
  19. Freshney RI (1986) Animal cell culture: a practical approach. IRL Press, OxfordGoogle Scholar
  20. Gamel JW, Vogel RL (2001) Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res 10:339–352CrossRefGoogle Scholar
  21. Gordon KE, Binas B, Chapman RS, Kurian KM, Clarkson RW, Clark AJ, Lane EB, Watson CJ (2000) A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland. Breast Cancer Res 2:222CrossRefGoogle Scholar
  22. Gosens MJ, van Kempen LC, van de Velde CJ, van Krieken JHJ, Nagtegaal ID (2007) Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol 20:221–232CrossRefGoogle Scholar
  23. Hammond SL, Ham RG, Stampfer MR (1984) Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81:5435–5439CrossRefGoogle Scholar
  24. Harris RE, Namboodiri KK, Wynder EL (1992) Breast cancer risk: effects of estrogen replacement therapy and body mass. J Natl Cancer Inst 84:1575–1582CrossRefGoogle Scholar
  25. Henderson IC (1993) Risk factors for breast cancer development. Cancer 71:2127–2140CrossRefGoogle Scholar
  26. Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74:424–429CrossRefGoogle Scholar
  27. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1979) Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76:1438–1442CrossRefGoogle Scholar
  28. Honeth G, Bendahl P-O, Ringnér M, Saal LH, Gruvberger-Saal SK, Lovgren K, Grabau D, Ferno M, Borg A, Hegardt C (2008) The CD44 +/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10:R53CrossRefGoogle Scholar
  29. Hopper JL (2001) Genetic epidemiology of female breast cancer. Semin Cancer Biol 11:367–374CrossRefGoogle Scholar
  30. Jazayeri SB, Saadat S, Ramezani R, Kaviani A (2015) Incidence of primary breast cancer in Iran: ten-year national cancer registry data report. Cancer Epidemiol 39:519–527CrossRefGoogle Scholar
  31. Johanson JF (2001) Critical review of the epidemiology of gastroesophageal reflux disease with specific comparisons to asthma and breast cancer. Am J Gastroenterol 96:S19–S21CrossRefGoogle Scholar
  32. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, DiMeo TA, Gilmore H, Jefferson DM, Graham RA (2010) Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 12:R87CrossRefGoogle Scholar
  33. Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140CrossRefGoogle Scholar
  34. Kristiansen G, Sammar M, Altevogt P (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35:255–262CrossRefGoogle Scholar
  35. Leccia F, Nardone A, Corvigno S, Vecchio LD, De Placido S, Salvatore F, Veneziani BM (2012) Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry Part A 81:960–972CrossRefGoogle Scholar
  36. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R (1992) Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89:2504–2508CrossRefGoogle Scholar
  37. Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M (2011) Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches. Br J Cancer 104:1739–1746CrossRefGoogle Scholar
  38. Lesley J, Hyman R, Kincade PW (1992) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271–335CrossRefGoogle Scholar
  39. Li C (2010) Breast cancer epidemiology. Springer, BerlinCrossRefGoogle Scholar
  40. Lim S (2005) CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother 59:S351–S354CrossRefGoogle Scholar
  41. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217–226CrossRefGoogle Scholar
  42. Liu Z, Miner JJ, Yago T, Yao L, Lupu F, Xia L, McEver RP (2010) Differential regulation of human and murine P-selectin expression and function in vivo. J Exp Med 207:2975–2987CrossRefGoogle Scholar
  43. Martz E, Phillips H, Steinberg M (1974) Contact inhibition of overlapping and differential cell adhesion: a sufficient model for the control of certain cell culture morphologies. J Cell Sci 16:401–419Google Scholar
  44. Mennan C, Wright K, Bhattacharjee A, Balain B, Richardson J, Roberts S (2013) Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord. Biomed Res Int 2013:916136. CrossRefGoogle Scholar
  45. Movahedi M, Haghighat S, Khayamzadeh M, Moradi A, Ghanbari-Motlagh A, Mirzaei H, Esmail-Akbari M (2012) Survival rate of breast cancer based on geographical variation in Iran, a national study. Iran Red Crescent Med J 14:798CrossRefGoogle Scholar
  46. Munz M, Fellinger K, Hofmann T, Schmitt B, Gires O (2007) Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. Front Biosci J Virtual Libr 13:5195–5201Google Scholar
  47. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515–527CrossRefGoogle Scholar
  48. Pauli C, Münz M, Kieu C, Mack B, Breinl P, Wollenberg B, Lang S, Zeidler R, Gires O (2003) Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett 193:25–32CrossRefGoogle Scholar
  49. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefGoogle Scholar
  50. Phuchareon J, Ohta Y, Woo JM, Eisele DW, Tetsu O (2009) Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS ONE 4:e6040CrossRefGoogle Scholar
  51. Rhyner JA, Koller M, Durussel-Gerber I, Cox JA, Strehler EE (1992) Characterization of the human calmodulin-like protein expressed in Escherichia coli. Biochemistry 31:12826–12832CrossRefGoogle Scholar
  52. Rogers MS, Strehler EE (2001) The tumor-sensitive calmodulin-like protein is a specific light chain of human unconventional myosin X. J Biol Chem 276:12182–12189CrossRefGoogle Scholar
  53. Rogers MS, Foleyt MA, Crotty TB, Hartmannt LC, Ingle JN, Roche PC, Strehler EE (1999) Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development. Neoplasia 1:220–225CrossRefGoogle Scholar
  54. Romano P, Manniello A, Aresu O, Armento M, Cesaro M, Parodi B (2009) Cell line data base: structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res 37:D925–D932CrossRefGoogle Scholar
  55. Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76:69–125CrossRefGoogle Scholar
  56. Rosner B, Gore R (2001) Measurement error correction in nutritional epidemiology based on individual foods, with application to the relation of diet to breast cancer. Am J Epidemiol 154:827–835CrossRefGoogle Scholar
  57. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ (2004) The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate 58:382–393CrossRefGoogle Scholar
  58. Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849–5855CrossRefGoogle Scholar
  59. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3:1101–1108CrossRefGoogle Scholar
  60. Shah K (2015) Primary cells versus cell lines. Retrieved 27 Feb 2017
  61. Shi S-R, Cote RJ, Taylor CR (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45:327–343CrossRefGoogle Scholar
  62. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259–273CrossRefGoogle Scholar
  63. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRefGoogle Scholar
  64. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ (2005) CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 8:R7CrossRefGoogle Scholar
  65. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen M, Van de Rijn M, Jeffrey S (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874CrossRefGoogle Scholar
  66. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Van De Rijn M, Jeffrey SS (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874CrossRefGoogle Scholar
  67. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423CrossRefGoogle Scholar
  68. Speirs V, Green AR, White MC (1996) A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples. Int J Cancer 66:551–556CrossRefGoogle Scholar
  69. Speirs V, Green A, Walton D, Kerin M, Fox J, Carleton P, Desai S, Atkin S (1998) Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer 78:1421–1429CrossRefGoogle Scholar
  70. Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103:483–488CrossRefGoogle Scholar
  71. Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, Pourhoseingholi MA (2012) Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev 13:367–370CrossRefGoogle Scholar
  72. Tan P-H, Bay B-H, Yip G, Selvarajan S, Tan P, Wu J, Lee C-H, Li K-B (2005) Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 18:374–381CrossRefGoogle Scholar
  73. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane E, Leigh I (1989) Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 94:403–413Google Scholar
  74. Vineis P, Wild CP (2014) Global cancer patterns: causes and prevention. Lancet 383:549–557CrossRefGoogle Scholar
  75. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G, Baeuerle P (2006) Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94:128–135CrossRefGoogle Scholar
  76. Winter MJ, Nagtegaal ID, van Krieken JHJ, Litvinov SV (2003) The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163:2139–2148CrossRefGoogle Scholar
  77. Yaswen P, Smoll A, Peehl DM, Trask DK, Sager R, Stampfer MR (1990) Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc Natl Acad Sci USA 87:7360–7364CrossRefGoogle Scholar
  78. ZenBio Scientific Publications (2015) Primary cell culture: the game has changed! ZenBio Scientific Publications. Retrieved 27 Feb 2017
  79. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale A-L (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15:2523–2536CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2018

Authors and Affiliations

  1. 1.Department of Clinical Biochemistry, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  2. 2.Department of Hematology, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  3. 3.Iranian Biological Resource CenterTehranIran
  4. 4.Atieh HospitalTehranIran
  5. 5.Department of Microbiology, Immunology and Molecular GeneticsUniversity of California, Los Angeles, UCLALos AngelesUSA
  6. 6.Cancer Institute, Imam Khomeini HospitalTehran University of Medical ScienceTehranIran

Personalised recommendations